Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 42
Titolo Data di pubblicazione Autore(i) File
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 1-gen-2024 Stefanini, Bernardo; Manfredi, Giulia F.; D'Alessio, Antonio; Fulgenzi, Claudia A. M.; Awosika, Nichola; Celsa, Ciro; Pirisi, Mario; Rigamonti, Cristina; Burlone, Michela; Vincenzi, Federica; Minisini, Rosalba; Gennari, Alessandra; Yip, Vincent; Slater, Sarah; El-Shakankery, Karim; Jain, Ananya; Tovoli, Francesco; Piscaglia, Fabio; Spalding, Duncan; Pai, Madhava; Pinato, David J.
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 1-gen-2024 Celsa, Ciro; Cabibbo, Giuseppe; Fulgenzi, Claudia Angela Maria; Battaglia, Salvatore; Enea, Marco; Scheiner, Bernhard; D'Alessio, Antonio; Manfredi, Giulia F.; Stefanini, Bernardo; Nishida, Naoshi; Galle, Peter R.; Schulze, Kornelius; Wege, Henning; Ciccia, Roberta; Hsu, Wei-Fan; Vivaldi, Caterina; Wietharn, Brooke; Lin, Ryan Po-Ting; Pirozzi, Angelo; Pressiani, Tiziana; Dalbeni, Andrea; Natola, Leonardo A.; Auriemma, Alessandra; Rigamonti, Cristina; Burlone, Michela; Parisi, Alessandro; Huang, Yi-Hsiang; Lee, Pei-Chang; Ang, Celina; Marron, Thomas U.; Pinter, Matthias; Cheon, Jaekyung; Phen, Samuel; Singal, Amit G; Gampa, Anuhya; Pillai, Anjana; Roehlen, Natascha; Thimme, Robert; Vogel, Arndt; Soror, Noha; Ulahannan, Susanna; Sharma, Rohini; Sacerdoti, David; Pirisi, Mario; Rimassa, Lorenza; Lin, Chun-Yen; Saeed, Anwaar; Masi, Gianluca; Schönlein, Martin; von Felden, Johann; Kudo, Masatoshi; Cortellini, Alessio; Chon, Hong Jae; Cammà, Calogero; Pinato, David James
From MASH to HCC: the role of Gas6/TAM receptors 1-gen-2024 Apostolo, Daria; Ferreira, Luciana L.; Vincenzi, Federica; Vercellino, Nicole; Minisini, Rosalba; Latini, Federico; Ferrari, Barbara; Burlone, Michela E.; Pirisi, Mario; Bellan, Mattia
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 1-gen-2023 Manfredi, Giulia Francesca; Celsa, Ciro; John, Chloe; Jones, Charlotte; Acuti, Nicole; Scheiner, Bernhard; Fulgenzi, Claudia Angela Maria; Korolewicz, James; Pinter, Matthias; Gennari, Alessandra; Mauri, Francesco A; Pirisi, Mario; Minisini, Rosalba; Vincenzi, Federica; Burlone, Michela; Rigamonti, Cristina; Donadon, Matteo; Cabibbo, Giuseppe; D'Alessio, Antonio; Pinato, David James
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 1-gen-2023 Caviglia, Gian Paolo; Abate, Maria Lorena; Troshina, Giulia; Carucci, Patrizia; Rolle, Emanuela; Risso, Alessandra; Burlone, Michela Emma; Albè, Alice; Crevola, Martina; Musso, Emma Clara; Rosso, Chiara; Armandi, Angelo; Olivero, Antonella; Minisini, Rosalba; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Pirisi, Mario; Ciancio, Alessia; Gaia, Silvia
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 1-gen-2023 Sacco, Rodolfo; Ramai, Daryl; Tortora, Raffaella; di Costanzo, Giovan Giuseppe; Burlone, Michela Emma; Pirisi, Mario; Federico, Piera; Daniele, Bruno; Silletta, Marianna; Gallo, Paolo; Cocuzza, Caterina; Russello, Maurizio; Cabibbo, Giuseppe; Rancatore, Gabriele; Cesario, Silvia; Masi, Gianluca; Marzi, Luca; Mega, Andrea; Granito, Alessandro; Pieri, Giulia; Giannini, Edoardo G; Paolillo, Rosa; Gadaleta-Caldarola, Gennaro; Dadduzio, Vincenzo; Giordano, Guido; Giacomelli, Luca; Papa, Simonetta; Renzulli, Matteo; Maida, Marcello; Ghidini, Michele; Borzio, Mauro; Facciorusso, Antonio
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 1-gen-2022 Burlone, M. E.; Bellan, M.; Barbaglia, M. N.; Mocchetti, G.; Mallela, V. R.; Minisini, R.; Rigamonti, C.; Pirisi, M.
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 1-gen-2022 Barbaglia, Matteo Nazzareno; Harris, James Michael; Smirnov, Artem; Burlone, Michela Emma; Rigamonti, Cristina; Pirisi, Mario; Minisini, Rosalba; Magri, Andrea
Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis 1-gen-2021 Martelletti, C.; Ricotti, A.; Gesualdo, M.; Carucci, P.; Gaia, S.; Rolle, E.; Burlone, M. E.; Okolicsanyi, S.; Mattalia, A.; Pirisi, M.; Berchialla, P.; Tabone, M.
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 1-gen-2020 Vaghi, G.; Gori, B.; Strigaro, G.; Burlone, M.; Minisini, R.; Barbaglia, M. N.; Brigatti, E.; Varrasi, C.; Pirisi, M.; Cantello, R.
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 1-gen-2020 Burlone, MICHELA Emma; Fangazio, Stefano; Croce, Alessandro; Ceriani, Elisa; Rapetti, Rachele; Rigamonti, Cristina; Smirne, Carlo; Tonello, Stelvio; Ravanini, Paolo; Minisini, Rosalba; Pirisi, Mario
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 1-gen-2020 De Benedittis, C.; Bellan, M.; Crevola, M.; Boin, E.; Barbaglia, M. N.; Mallela, V. R.; Ravanini, P.; Ceriani, E.; Fangazio, S.; Sainaghi, P. P.; Burlone, M. E.; Minisini, R.; Pirisi, M.
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 1-gen-2020 Smirne, Carlo; Mulas, Violante; Barbaglia, Matteo Nazzareno; Ramana Mallela, Venkata; Minisini, Rosalba; Barizzone, Nadia; Burlone, MICHELA Emma; Pirisi, Mario; Grossini, Elena
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 1-gen-2019 Bellan, M.; Rigamonti, C.; Giacomini, G. M.; Makmur, G.; Marconi, C.; Nicosia, F.; Panero, A.; De Benedittis, C.; Burlone, M. E.; Minisini, R.; Pirisi, M.
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 1-gen-2019 Smirne, C.; Rigamonti, C.; DE BENEDITTIS, Carla; Sainaghi, P. P.; Bellan, M.; Burlone, M. E.; Castello, L. M.; Avanzi, G. C.
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 1-gen-2019 Bellan, M.; Giubertoni, A.; Piccinino, Cristina; Dimagli, Arnaldo; Grimoldi, F.; Sguazzotti, M.; Burlone, M. E.; Smirne, C.; Sola, D.; Marino, P.; Pirisi, M.; Sainaghi, P. P.
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 1-gen-2019 Howell, J.; Atkinson, S. R.; Pinato, D. J.; Knapp, S.; Ward, C.; Minisini, R.; Burlone, M. E.; Leutner, M.; Pirisi, M.; Buttner, R.; Khan, S. A.; Thursz, M.; Odenthal, M.; Sharma, R.
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 1-gen-2018 Bruzzì, Stefania; Sutti, Salvatore; Giudici, Gabriele; Burlone, Michela E; Ramavath, Naresh Naik; Toscani, Alberto; Bozzola, Cristina; Schneider, Pascal; Morello, Elisabetta; Parola, Maurizio; Pirisi, Mario; Albano, Emanuele
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 1-gen-2018 Bruzzì, Stefania; Sutti, Salvatore; Giudici, Gabriele; Burlone, Michela E.; Ramavath, NARESH NAIK; Toscani, Alberto; Bozzola, Cristina; Schneider, Pascal; Morello, Elisabetta; Parola, Maurizio; Pirisi, Mario; Albano, Emanuele
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 1-gen-2018 Gualerzi, Alessandro; Bellan, Mattia; Smirne, Carlo; TRAN MINH, Margherita; Rigamonti, Cristina; Burlone, Michela Emma; Bonometti, Ramona; Bianco, Sara; Re, Azzurra; Favretto, Serena; Bellomo, Giorgio; Minisini, Rosalba; Carnevale Schianca, Gian Piero; Pirisi, Mario
Mostrati risultati da 1 a 20 di 42
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile